Your browser doesn't support javascript.
loading
Effectiveness of food supplement on treatment outcomes and quality of life in pulmonary tuberculosis: Phased implementation approach.
Mahapatra, Amarendra; Thiruvengadam, Kannan; Nair, Dina; Padmapriyadarsini, Chandrasekaran; Thomas, Beena; Pati, Sanghamitra; Bulliyya, Gandham; Das, Dasarathi; Chowdhury, Jayeeta; Bang, Anand; Swaminathan, Soumya.
Afiliação
  • Mahapatra A; ICMR-Regional Medical Research Centre, Bhubaneswar, Odisha, India.
  • Thiruvengadam K; ICMR-National Institute for Research in Tuberculosis, Chennai, India.
  • Nair D; ICMR-National Institute for Research in Tuberculosis, Chennai, India.
  • Padmapriyadarsini C; ICMR-National Institute for Research in Tuberculosis, Chennai, India.
  • Thomas B; ICMR-National Institute for Research in Tuberculosis, Chennai, India.
  • Pati S; ICMR-Regional Medical Research Centre, Bhubaneswar, Odisha, India.
  • Bulliyya G; ICMR-Regional Medical Research Centre, Bhubaneswar, Odisha, India.
  • Das D; ICMR-Regional Medical Research Centre, Bhubaneswar, Odisha, India.
  • Chowdhury J; Tata Trusts, Mumbai, India.
  • Bang A; Tata Trusts, Mumbai, India.
  • Swaminathan S; Indian Council of Medical Research, New Delhi, India.
PLoS One ; 19(7): e0305855, 2024.
Article em En | MEDLINE | ID: mdl-39012889
ABSTRACT

BACKGROUND:

By encouraging treatment adherence and lowering mortality, dietary supplements can serve as adjuvant therapy for the success of medical interventions. We determined the effect of locally accessible food supplements on treatment outcomes, and health-related quality of life in patients with pulmonary tuberculosis initiating anti-tuberculosis treatment (ATT) in Odisha, India.

METHOD:

Between September 2017 and December 2018, implementation research in patients with newly diagnosed sputum smear-positive pulmonary tuberculosis initiating ATT in five districts of the tribal belt of Odisha, offered food supplements along with ATT in a phased manner. Clinical symptoms, anthropometry, sputum for M. tuberculosis (M. tb), health-related quality of life and return to normal function were assessed periodically, and favourable treatment outcome (cure or treatment completed) was measured at the end of treatment. The effect of the food supplement on unfavorable outcomes (treatment failure, death, or lost-to-follow-up) was modelled using mixed-effects Poisson regression to determine the risk factors.

RESULTS:

Among the 761 participants enrolled, 614 participants received the food supplement and 147 did not receive the food supplement. Among the 614 participants in the supplement group, 537 (87%) had a favorable outcome and among the 147 participants in the no-supplement group, 113 (77%) had a favorable outcome (p = 0.0017). Higher age (>55 years) [aRR = 2.1(95% CI 1.1-3.8)], male gender [aRR = 1.7(95% CI 1.2-2.9)], and smear grading ≥2+ [aRR = 1.5 (95% CI 1.1-2.2)] were associated with unfavorable treatment outcomes. Nutritional status, quality of life and lung health showed significant improvement from baseline in the supplement group.

CONCLUSION:

Improvement in the nutritional status of the patient can be considered a predictor of treatment success rates. Early food supplementation has a positive impact on the nutritional status.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Tuberculose Pulmonar / Suplementos Nutricionais / Antituberculosos Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Tuberculose Pulmonar / Suplementos Nutricionais / Antituberculosos Idioma: En Ano de publicação: 2024 Tipo de documento: Article